ArcherDx VariantPlex Core Myeloid Panel
ArcherDx has launched the Archer VariantPlex Core Myeloid panel, a next-generation sequencing-based targeted panel that analyzes 37 genes related to myeloid malignancies. The company said the panel uses molecular barcoded reads, and can detect FLT3 internal tandem duplications, variants that are present in more than 20 percent of acute myeloid leukemia cases and are challenging to detect in NGS data. VariantPlex assays are provided in eight-strip, single-use lyophilized library preparation reagents that require no master mixes.
ArcherDx said that it also plans to launch a VariantPlex Myeloid panel, which expands the number of genes to 72.